宜明昂科生物医药技术（上海）股份有限公司（股票名称：宜明昂科-B，股票代码：01541）于2026年7月7日发布公告，披露公司在香港联交所场内回购共计91,800股H股，占本次回购前公司已发行股本0.0219%。本次回购价格区间为每股3.57港元至3.86港元，合计支付金额337,936港元（约33.79万港元）。
公告显示，回购完成后公司已发行股本数为418,809,905股，库存股数量增至1,667,400股。据悉，公司于2026年5月28日获得回购授权，可购回的股份总数为43,150,769股，至今累计已回购并持有的股份数量占授权时公司已发行股本约0.386%。公司确认本次股份购回已严格遵守香港联交所上市规则及相关法例的要求。
公告由执行董事、联席公司秘书关梅签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.